10: neurotrophics Flashcards Preview

NEURO 410 > 10: neurotrophics > Flashcards

Flashcards in 10: neurotrophics Deck (27):
1

neurodegenerative diseases characterized by? curable? why (2)?

death of specific neuronal populations. most CNS neurodegen. diseases are incurable: poor knowledge of etiology, difficult access of brain

2

goal of neurorestoration

to protect neurons, promote neuroregeneration

3

strategy of neurorestoration?

to use NTFs, neurotrophic factors, to protect neurons and achieve neurorestoration

4

what are NTFs?

small proteins that are secreted, and regulate the NS's development, maintenance, plasticity

5

NTFs regulate which 3 main processes? bind to?

endogenous neuroprotection, neurogenesis, neurorestoration. bind to receptors expressed on surface of responsive cells and activate signaling mechanisms (transcriptional activation, cellular metabolism, synaptic palsticity)

6

3 families of neurotrophic factors

neurotrophins/NTs. GDNF family of ligands. neurokines.

7

neurotrophins family: 4?

nerve growth factor NGF. brain derived neurotrophic factor BDNF. NT3. NT4.

8

GDNF famil? (4)

glial derived neurotrophic factor GDNF. neurturin NRTN. artemin ARTN. persephin PSPN

9

neurkines family: which factor?

ciliary neurotrophic factor CNTF

10

neurotrophic factors stimulate 3 things?

neuronal survival, neuronal function, axonal growth

11

classical vs. current neurotrophic model

classical: target cells release NTFs, taken up by terminal axons then retrograde transport to cell body. current: glial cells also secrete, and NTFs onto cell body as well as and the target cell too

12

why use NTFs in neurodegen. disorders? (2)

decrease in NTFs levels play a role in pathogenesis of AD, HD, PD. large number of studies supports their use: prevents/slows cell death, enhances regeneration after injury

13

AD: degree of dementia correlates best with? what do they do?

degeneration of BFCNs, basal forebrain cholinergic neurons, which project to cerebral cortex, hippocampus, nucleus basalis - important for learning and memory

14

BFCNs and relation to NTFs?

basal forebrain cholinergic neurons highly dependent on NGF supply during adulthood. depletion = reduce # of cholinergic neurons, atrophy of chol neurons, reduction in chol innervation of hippocampus

15

NGF administration into adult rat brain (2)?

for AD treatment: prevents death of BFCNs, improves learning and memory in lesioned and aged rats

16

NGF admin into mouse model of AD (2)?

reverses BFCN atrophy, improves neuronal function

17

2 limitations of NGF therapy

neuronal loss in AD is widespread: hard to treat whole brain with NGFs. there are multiple NT deficits in AD

18

NTFs in HD?

medium spiny neurons depende on cortically derived BDNF. in HD, cortical BDNF is reduced to 50%.

19

HD: what gene for what NTF? mutation? post mortem HD brain shows?

Htt induces BDNF gene expression. mutant Htt negatively affects BDNF gene expression. lower BDNF mRNA and protein levels in cortex.

20

critical role in HD: loss of what? caused by what? prime target for therapeutics?

loss of neurotrophic support in striatum caused by reduced levels of BDNF. restoring BDNF signalling

21

2 other NTFs important in HD

NGF: supports cholinergic neurons in striatum, but not GABAergic neurons. CNTF: supports cholinergic and GABAergic neurons

22

5 limitations of NTFs for treatment of neurodegen disorders?

inability to cross BBB. pleiotropic effects following systemic application. poor stability in fluid environment (short half life in vivo, poor pharmokinetic properties). limited diffusion through brain parenchyma. side effects associated with binding to extra-target receptors.

23

what is curcial in succesful therapy?

NTF delivery to proper site

24

parental systemic administrcation: via? how to use?

nanocarriers: injected IV, then cross BBB and reaches brain parenchyma

25

what are nanocarriers? effects?

liposome based formulation loaded with GDNF and targeted to brain with mAb against TfR. general improvement of PD symptoms

26

nanocarriers are targeted by?

coating the surface of the material with peptides (ex with targeting ligands)

27

how do nanocarriers get in?

injected IV. then cross BBB: receptor mediated transcytosis, or absoprtive transcytosis (because of coating with positive charges)